UPDATED Apr 18, 2024
All the companies in the healthcare sector, including healthcare provider and equipment, healthcare tech, pharmaceuticals, biotech and life sciences.
Company | Last Price | 7D Return | 1Y Return | Market Cap | Analysts Target | Valuation | Growth | Div Yield | Industry | ||
---|---|---|---|---|---|---|---|---|---|---|---|
NOVN | CHF84.52 | -1.3% | -4.1% | CHF185.1b | CHF97.34 | PE23.7x | E9.5% | 3.9% | Pharmaceuticals & Biotech | ||
ROG | CHF220.00 | -2.7% | -20.7% | CHF177.2b | CHF281.61 | PE15.3x | E8.1% | 4.4% | Pharmaceuticals & Biotech | ||
LONN | CHF510.20 | -5.6% | -10.4% | CHF36.8b | CHF566.00 | PE56.3x | E19.9% | 0.8% | Pharmaceuticals & Biotech | ||
ALC | CHF72.12 | -3.6% | 12.9% | CHF35.6b | CHF85.20 | PE40x | E10.5% | 0.3% | Healthcare | ||
STMN | CHF134.40 | -5.1% | -1.9% | CHF21.4b | CHF141.56 | PE87.1x | E23.6% | 0.6% | Healthcare | ||
GALD | CHF63.60 | 2.3% | n/a | CHF15.1b | n/a | n/a | n/a | n/a | Pharmaceuticals & Biotech | ||
SOON | CHF248.70 | -3.7% | -12.5% | CHF14.8b | CHF271.47 | PE24.7x | E10.7% | 1.8% | Healthcare | ||
SDZ | CHF28.70 | 9.8% | n/a | CHF12.3b | CHF34.91 | PE175.5x | E30.0% | 1.6% | Pharmaceuticals & Biotech | ||
BANB | CHF78.55 | -5.2% | -16.3% | CHF5.9b | CHF70.80 | PE52.6x | E15.4% | 1.0% | Pharmaceuticals & Biotech | ||
YPSN | CHF380.00 | 1.3% | 93.5% | CHF5.2b | CHF365.00 | PE71.6x | E31.1% | 0.3% | Healthcare | ||
TECN | CHF321.80 | -7.7% | -17.8% | CHF4.1b | CHF395.57 | PE31.2x | E9.2% | 0.9% | Pharmaceuticals & Biotech | ||
SFZN | CHF877.00 | -2.2% | 31.3% | CHF3.8b | CHF1,015.90 | PE33.4x | E14.7% | 0.4% | Pharmaceuticals & Biotech | ||
GALE | CHF69.85 | -3.9% | -11.8% | CHF3.5b | CHF76.25 | PE21.1x | E5.2% | 3.1% | Healthcare | ||
DESN | CHF221.50 | -3.5% | -6.7% | CHF3.1b | n/a | PE35.4x | S11.2% | 0% | Pharmaceuticals & Biotech | ||
MOVE | CHF110.40 | -8.5% | -1.1% | CHF2.2b | CHF142.95 | PE47.8x | E21.8% | 0.5% | Healthcare | ||
SKAN | CHF78.00 | -4.2% | -8.5% | CHF1.8b | CHF91.33 | PE66.7x | E34.8% | 0.4% | Pharmaceuticals & Biotech | ||
AEVS | CHF15.05 | -0.7% | -17.8% | CHF1.3b | n/a | PS1.5x | n/a | 0% | Healthcare | ||
COPN | CHF71.20 | 2.3% | 29.9% | CHF1.1b | CHF93.67 | PE1026x | E30.4% | 2.7% | Pharmaceuticals & Biotech | ||
MED | CHF81.00 | 0% | 12.5% | CHF1.1b | CHF103.50 | PE1774.3x | E63.5% | n/a | Healthcare | ||
PPGN | CHF29.20 | -1.0% | 48.3% | CHF962.7m | CHF21.55 | PS3.1x | E0.07% | 0% | Pharmaceuticals & Biotech | ||
MEDX | CHF14.96 | -5.3% | -28.9% | CHF610.1m | CHF30.00 | PE2033.7x | E60.5% | 3.3% | Healthcare | ||
METN | CHF1,315.00 | -5.1% | -28.7% | CHF591.8m | n/a | PE26.6x | E7.3% | 1.5% | Healthcare | ||
BSLN | CHF41.95 | 3.5% | -4.8% | CHF503.5m | CHF70.58 | PE48.2x | E32.8% | 0% | Pharmaceuticals & Biotech | ||
IDIA | CHF1.95 | 4.8% | -79.5% | CHF348.7m | CHF1.72 | PS1.9x | E17.5% | n/a | Pharmaceuticals & Biotech |